Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report

被引:2
|
作者
Liu, Cong [1 ]
Zou, Cuicui [1 ]
Zou, Shuhui [1 ]
Wang, Qun [2 ]
Xiao, Dejun [1 ]
Zhang, Liqin [1 ]
机构
[1] Ganzhou Peoples Hosp, Ganzhou 341000, Jiangxi, Peoples R China
[2] Luneng Biotechnol Shenzhen Co LTD, Shenzhen 518000, Peoples R China
关键词
Myelodysplastic syndrome; Abnormal hemoglobin H band; ACUTE MYELOID-LEUKEMIA; SIDEROBLASTIC ANEMIA; ALPHA-THALASSEMIA; INACTIVATION; CYTOGENETICS; EXPRESSION; SURVIVAL; CHILDREN; GENE;
D O I
10.1016/j.tracli.2020.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myelodysplastic syndrome (MDS) is a group of heterogeneous diseases derived from hematopoietic stem cells characterized by hemolytic anemia and high risk of conversion to acute leukemia. MDS is an age-related disease in which approximately 80% of patients are over 60years of age, male and female. Anemia is the most common clinical condition, and many patients are also associated with infection and bleeding. When the amount of alpha globin synthesis is insufficient, the remaining beta chain forms tetramer beta 4, i.e. HbH. The latter forms a precipitate in red blood cells, leading to hemolytic anemia, called HbH disease, the majority of which is congenital, a small number of patients with myelodysplastic syndrome and acute myeloid leukemia may appear HbH (called acquired HbH disease). We reported a 71years old male patient diagnosed as myelodysplastic syndromes (MDS) in our hospital. The patient has a negative alpha-thalassemia gene test. The H band is detected by hemoglobin electrophoresis. This article analyzed and discussed this case with MDS, as well reviewed MDS. (C) 2020 Published by Elsevier Masson SAS on behalf of Societe francaise de transfusion sanguine(SFTS).
引用
收藏
页码:206 / 210
页数:5
相关论文
共 50 条
  • [21] MYELODYSPLASTIC SYNDROMES (MDS) IN CENTRAL AFRICANS
    MUKIIBI, JM
    PAUL, B
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1994, 46 (01): : 17 - 19
  • [22] GRANULOCYTIC SARCOMAS IN MYELODYSPLASTIC SYNDROMES (MDS)
    DASILVA, MAP
    MORIARTY, A
    TRICOT, GJ
    BLUT, 1988, 56 (06): : C7 - C7
  • [23] Mutations of myelodysplastic syndromes (MDS): An update
    Ganguly, Bani Bandana
    Kadam, N. N.
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 47 - 62
  • [24] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Iannella, E.
    Levi, A.
    Natalino, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2007, 31 : S107 - S107
  • [25] Iron overload in myelodysplastic syndromes (MDS)
    Gattermann, Norbert
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) : 55 - 63
  • [26] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [27] Cytogenetic changes in myelodysplastic syndromes (MDS)
    Haus, O
    Kotlarek-Haus, S
    Czarnecka, M
    Potoczek, S
    Kyrcz-Krzemien, S
    Duszenko, E
    Makowska, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 71 - 71
  • [28] Recent advances in myelodysplastic syndromes (MDS)
    Ascari, E
    HAEMATOLOGICA, 1998, 83 (03) : 287 - 288
  • [29] Does thrombocytosis alter the, prognosis of myelodysplastic syndromes (MDS) and MDS/myeloproloferative syndromes (MDS/MPD)? A matched case-control analysis of outcomes
    Kodali, Dhatri
    Mesa, Hector
    Rawal, Ajay
    Cao, Qing
    Gupta, Pankaj
    BLOOD, 2007, 110 (11) : 728A - 728A
  • [30] REPORT ABOUT A CASE OF FAMILIAL MYELODYSPLASTIC SYNDROME (MDS)
    NARDELLI, S
    CICCONE, F
    MODESTI, A
    CUPELLARO, E
    DERIU, L
    BLUT, 1988, 56 (06): : C3 - C3